Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04475731
Recruitment Status : Not yet recruiting
First Posted : July 17, 2020
Last Update Posted : January 5, 2021
Sponsor:
Information provided by (Responsible Party):
Gruppo Italiano Malattie EMatologiche dell'Adulto

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : November 2022
Estimated Study Completion Date : November 2024